BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20451460)

  • 1. Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.
    Foster AD; Haas M; Puliaeva I; Soloviova K; Puliaev R; Via CS
    Clin Immunol; 2010 Jul; 136(1):61-73. PubMed ID: 20451460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor CD8 T cells and IFN-gamma are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice.
    Foster AD; Soloviova K; Puliaeva I; Puliaiev M; Puliaev R; Finkelman F; Via CS
    J Immunol; 2011 Jun; 186(11):6238-54. PubMed ID: 21531893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.
    Yu XZ; Liang Y; Nurieva RI; Guo F; Anasetti C; Dong C
    J Immunol; 2006 Jun; 176(12):7394-401. PubMed ID: 16751384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease.
    Kuroiwa T; Iwasaki T; Imado T; Sekiguchi M; Fujimoto J; Sano H
    Arthritis Res Ther; 2006; 8(4):R123. PubMed ID: 16859527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.
    Soloviova K; Puliaiev M; Haas M; Dalgard CL; Schaefer BC; Via CS
    J Immunol; 2015 Oct; 195(7):2985-3000. PubMed ID: 26320249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis.
    Sainis K; Datta SK
    J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells.
    Lang TJ; Nguyen P; Papadimitriou JC; Via CS
    J Immunol; 2003 Dec; 171(11):5795-801. PubMed ID: 14634088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β-Induced CD8
    Zhong H; Liu Y; Xu Z; Liang P; Yang H; Zhang X; Zhao J; Chen J; Fu S; Tang Y; Lv J; Wang J; Olsen N; Xu A; Zheng SG
    Front Immunol; 2018; 9():35. PubMed ID: 29441062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells, murine chronic graft-versus-host disease and autoimmunity.
    Eisenberg RA; Via CS
    J Autoimmun; 2012 Sep; 39(3):240-7. PubMed ID: 22704961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.
    Brown GR; Lee E; Thiele DL
    J Immunol; 2002 Mar; 168(6):3065-71. PubMed ID: 11884480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18 prevents the development of chronic graft-versus-host disease in mice.
    Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M
    J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses.
    Puliaeva I; Puliaev R; Shustov A; Haas M; Via CS
    J Immunol; 2008 Nov; 181(9):5912-29. PubMed ID: 18941180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD.
    Dutt S; Baker J; Kohrt HE; Kambham N; Sanyal M; Negrin RS; Strober S
    Blood; 2011 Mar; 117(11):3230-9. PubMed ID: 21239702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.
    Rus V; Svetic A; Nguyen P; Gause WC; Via CS
    J Immunol; 1995 Sep; 155(5):2396-406. PubMed ID: 7650373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher frequencies of circulating ICOS
    Zhang Z; Shi Y; Yang K; Crew R; Wang H; Jiang Y
    Autoimmunity; 2017 Dec; 50(8):458-467. PubMed ID: 29025273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.
    Sato M; Storb R; Loretz C; Stone D; Mielcarek M; Sale GE; Rezvani AR; Graves SS
    Transplantation; 2013 Jul; 96(1):34-41. PubMed ID: 23694952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
    Schattenfroh NC; Hoffman RA; McCarthy SA; Simmons RL
    Transplantation; 1995 Jan; 59(2):268-73. PubMed ID: 7839451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.